Perrigo | PRGO - Assets


Perrigo reported $7.61B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AbbVie USD 135.12B 1.35B Jun/2026
Abbott USD 110.43B 23.72B Mar/2026
Bayer EUR 107.29B 659M Jun/2026
Bristol-Myers Squibb USD 88.77B 1.14B Sep/2026
Coherus Biosciences USD 191.18M 74.84M Jun/2026
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Dr.Reddys Laboratories INR 576.31B 1.01B Sep/2026
Eli Lilly USD 148.07B 5.79B Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Merck USD 129.8B 1.12B Jun/2026
Nestle CHF 128.38B 1.23B Jun/2026
Pacira USD 1.24B 35.44M Jun/2026
Perrigo USD 7.61B 373.8M Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026
Phibro Animal Health USD 1.5B 56.12M Jun/2026
Prestige Brands USD 4.57B 1.07B Jun/2026
Reckitt Benckiser GBP 25.3B 1.11B Dec/2024
Sanofi EUR 130.29B 1.23B Sep/2026
Supernus Pharmaceuticals USD 1.4B 30.42M Sep/2026
Teva Pharmaceutical Industries USD 39.86B 183M Jun/2026
Xeris Pharmaceuticals USD 411.9M 19.89M Jun/2026
Zoetis USD 15.08B 77M Jun/2026